IKT
Inhibikase·NASDAQ
--
--(--)
--
--(--)
IKT fundamentals
Inhibikase (IKT) released its earnings on Aug 14, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.11 (YoY +83.33%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.11
+83.33%
Report date
Aug 14, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Inhibikase (IKT) key financial stats and ratios, covering profitability, financial health, and leverage.
Inhibikase (IKT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Inhibikase (IKT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Inhibikase (IKT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Inhibikase (IKT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Inhibikase (IKT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Inhibikase's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Inhibikase year over year?What is the market's earnings forecast for Inhibikase next quarter?What is Inhibikase's gross profit margin?What factors drove the changes in Inhibikase's revenue and profit?What guidance did Inhibikase's management provide for the next earnings period?What were the key takeaways from Inhibikase’s earnings call?Did Inhibikase beat or miss consensus estimates last quarter?
